NCT01948362View on ClinicalTrials.gov

Sulforadex in Healthy Volunteers SAD

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Stage, Prostate Cancer
Interventions
DRUG

Sulforadex

Active compound

DRUG

Alpha cyclodextrin

Placebo control

Trial Locations (1)

SW17 0RE

Richmond Pharmacology, London

Sponsors

Lead Sponsor

Evgen Pharma
All Listed Sponsors
lead

Evgen Pharma

INDUSTRY

NCT01948362 - Sulforadex in Healthy Volunteers SAD | Biotech Hunter | Biotech Hunter